Last reviewed · How we verify
Dengue Tetravalent Vaccine, Live — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
Dengue Tetravalent Vaccine, Live (Dengue Tetravalent Vaccine, Live) — Sanofi Pasteur, a Sanofi Company.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Dengue Tetravalent Vaccine, Live TARGET | Dengue Tetravalent Vaccine, Live | Sanofi Pasteur, a Sanofi Company | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Dengue Tetravalent Vaccine, Live CI watch — RSS
- Dengue Tetravalent Vaccine, Live CI watch — Atom
- Dengue Tetravalent Vaccine, Live CI watch — JSON
- Dengue Tetravalent Vaccine, Live alone — RSS
Cite this brief
Drug Landscape (2026). Dengue Tetravalent Vaccine, Live — Competitive Intelligence Brief. https://druglandscape.com/ci/dengue-tetravalent-vaccine-live. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab